Aclaris Therapeutics, Inc. (LON:0H8T)
London · Delayed Price · Currency is GBP · Price in USD 2.595
-0.010 (-0.38%)
Jan 6, 2026, 7:09 PM GMT
Aclaris Therapeutics Market Cap
Aclaris Therapeutics has a market cap or net worth of 212.69 million as of January 7, 2026. Its market cap has decreased by -18.06% in one year.
Market Cap
212.69M
Enterprise Value
90.49M
Revenue
11.71M
Ranking
n/a
PE Ratio
n/a
Stock Price
2.60
Market Cap Chart
Since October 7, 2015, Aclaris Therapeutics's market cap has increased from 140.05M to 212.69M, an increase of 51.87%. That is a compound annual growth rate of 4.16%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 6, 2026 | 212.69M | -12.22% |
| Dec 31, 2025 | 242.31M | 14.30% |
| Dec 31, 2024 | 212.00M | 263.06% |
| Dec 29, 2023 | 58.39M | -93.30% |
| Dec 30, 2022 | 871.66M | 32.58% |
| Dec 31, 2021 | 657.46M | 223.25% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 217.72B |
| GSK plc | 76.21B |
| Haleon | 33.53B |
| Smith & Nephew | 10.67B |
| Convatec Group | 4.76B |
| Hikma Pharmaceuticals | 3.51B |
| HUTCHMED (China) | 1.81B |
| Genus | 1.72B |